BIOMAT Database Logo BIOMAT Database Logo

Contribution to the regulation of virus replication in cells latently infected with human immunodeficiency virus 1. 1997

S Owatari, and J Zhang, and M Gao, and A Tanabe-Tochikura, and N Wakamiya, and H Tsuchie, and T Kurimura
Department of Viral Infections, Osaka University, Japan.

Monocytes/macrophages have been known to play an important role in the initiation and propagation of human immunodeficiency virus 1 (HIV-1) infection. To analyze the function of these cells during the clinical asymptomatic period of infection, we examined the effect of murine peritoneal macrophages and human peripheral blood macrophages on two cell lines latently infected with HIV-1, a promonocytic cell line, U1, and a T-cell line, ACH-2. Monokines of the murine peritoneal macrophages induced significant viral expression in U1, but not in ACH-2 cells. Experiments employing transient transfection of U937 and CEM cells with HIV long terminal repeat (LTR)-chloramphenicol acetyl transferase (CAT) plasmids indicated that the effect of these monokines was due to specific activation of the HIV LTR. In contrast, supernatants of human macrophages induced viral expression in both ACH-2 and U1 cells. These results suggest that several monokines are active in regulating the transition from the clinical asymptomatic period of HIV infection to progression to acquired immunodeficiency syndrome (AIDS).

UI MeSH Term Description Entries
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D002450 Cell Communication Any of several ways in which living cells of an organism communicate with one another, whether by direct contact between cells or by means of chemical signals carried by neurotransmitter substances, hormones, and cyclic AMP. Cell Interaction,Cell-to-Cell Interaction,Cell Communications,Cell Interactions,Cell to Cell Interaction,Cell-to-Cell Interactions,Communication, Cell,Communications, Cell,Interaction, Cell,Interaction, Cell-to-Cell,Interactions, Cell,Interactions, Cell-to-Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications

Related Publications

S Owatari, and J Zhang, and M Gao, and A Tanabe-Tochikura, and N Wakamiya, and H Tsuchie, and T Kurimura
Human herpesvirus 8 enhances human immunodeficiency virus replication in acutely infected cells and induces reactivation in latently infected cells.
October 2005, Blood,
S Owatari, and J Zhang, and M Gao, and A Tanabe-Tochikura, and N Wakamiya, and H Tsuchie, and T Kurimura
Inhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IkappaB kinase inhibitor.
February 2006, Antimicrobial agents and chemotherapy,
S Owatari, and J Zhang, and M Gao, and A Tanabe-Tochikura, and N Wakamiya, and H Tsuchie, and T Kurimura
Human choroid plexus cells can be latently infected with human immunodeficiency virus.
April 1989, Annals of neurology,
S Owatari, and J Zhang, and M Gao, and A Tanabe-Tochikura, and N Wakamiya, and H Tsuchie, and T Kurimura
Reduced Frequency of Cells Latently Infected With Replication-Competent Human Immunodeficiency Virus-1 in Virally Suppressed Individuals Living in Rakai, Uganda.
October 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
S Owatari, and J Zhang, and M Gao, and A Tanabe-Tochikura, and N Wakamiya, and H Tsuchie, and T Kurimura
Establishment of novel cell lines latently infected with human immunodeficiency virus 1.
January 2011, Acta virologica,
S Owatari, and J Zhang, and M Gao, and A Tanabe-Tochikura, and N Wakamiya, and H Tsuchie, and T Kurimura
Extrachromosomal human immunodeficiency virus type 1 sequences are methylated in latently infected U937 cells.
June 1992, Virology,
S Owatari, and J Zhang, and M Gao, and A Tanabe-Tochikura, and N Wakamiya, and H Tsuchie, and T Kurimura
Rapid expression of human immunodeficiency virus following activation of latently infected cells.
February 2006, Journal of virology,
S Owatari, and J Zhang, and M Gao, and A Tanabe-Tochikura, and N Wakamiya, and H Tsuchie, and T Kurimura
Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection.
December 2000, The Journal of infectious diseases,
S Owatari, and J Zhang, and M Gao, and A Tanabe-Tochikura, and N Wakamiya, and H Tsuchie, and T Kurimura
Substance P enhances HIV-1 replication in latently infected human immune cells.
December 2001, Journal of neuroimmunology,
S Owatari, and J Zhang, and M Gao, and A Tanabe-Tochikura, and N Wakamiya, and H Tsuchie, and T Kurimura
Decelerating decay of latently infected cells during prolonged therapy for human immunodeficiency virus type 1 infection.
September 2002, Journal of virology,
Copied contents to your clipboard!